Abstract
Objective To compare the use of new antipsychotic drugs （NAD） including Olanzapine, Risperidone and Qutipine in the treatment for children with schizophrenia. Methods 66 children patients were included in this study, according to the case disease condition history, we evaluated the efficacy and side effects with CGI and TESS before treatment, and at the 2nd,4th ,8th weeks after the treatment. Results The response rate of Risperidone, Olazapine and Qutipine are 71%, 85.7%, and 60% respectively. The total response rate is 72.7%. The rates of side effects are 21%, 33%, 30% respectively. Conclusion It suggested that NAD is effective and safe in the treatment for children schizot~hrenia patients. NAD has been widelv u.~d in children ~chi~nnhreni~ nutnnti~nt~ Key words: New antipsychotic drugs; Children schizophrenia
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
